Exposure to Extracellular Mitochondrial DNA During Pregnancy Induces a Pro-Inflammatory Response in Rat Placenta
Authors: da Silva Renee , Hula Nataliia , Kelly Gabrielle , Gorham Isabelle , Phillips Nicole , Goulopoulou Styliani 
Published: May 2024

Introduction: Mitochondrial DNA (mtDNA) is released in the cytosol or the extracellular space due to mitochondrial dysfunction or cell death. Extracellular mtDNA is recognized by the innate immune receptor Toll-like receptor 9 (TLR9) and induces pro-inflammatory and immunogenic responses. Circulating cell-free mtDNA (ccf-mtDNA) increases with advancing gestational age and abnormal concentrations have been reported in obstetric complications such as preeclampsia (PE). Placentas from women with PE exhibit signs of extensive inflammation; however, the contribution of ccf-mtDNA to placental inflammation during pregnancy has not been investigated. We hypothesized that in vivo exposure to extracellular mtDNA during pregnancy would induce an inflammatory response in rat placenta via activation of TLR9 signaling. Methods: We isolated mtDNA from liver of Sprague Dawley pregnant rats (gestational day: 14-15, term=22-23 days) and treated gestational age-matched dams with mtDNA (350ng/kgBW) or saline (control) via intravenous injection. Following 4 hours after treatment, maternal organs and fetoplacental units were collected and gene expression of cytokines and TLR9 were measured. Results: Plasma levels of mtDNA 4 hours after treatment were not different between saline and mtDNA-treated rats (2−ΔCT, median (IQR); saline: 2.75 (1.61) vs. mtDNA: 2.64 (1.29), p>0.05). Treatment with mtDNA increased mRNA expression of pro-inflammatory tumor necrosis factor-alpha (TNF-α) (saline: 0.65 (1.1) vs. mtDNA: 2.84 (1.9), p=0.015), interleukin (IL)-6 (saline: 0.32 (0.2) vs. mtDNA: 3.37 (4.3), p=0.008), and IL-1β (saline: 0.2 (0.93) vs. mtDNA: 4.7 (6.0), p=0.01) and decreased expression of anti-inflammatory IL-10 (saline: 1.6 (0.8) vs. mtDNA: 0.6 (0.8), p=0.001) in rat placentas. Expression of macrophage marker F4/80 (saline: 0.4 (1.0) vs. mtDNA: 2.41 (4.7), p=0.04) and monocyte chemoattractant protein-1 (MCP-1) (saline: 0.68 (0.54) vs. mtDNA: 2.0(1.96), p=0.041) also increased in rat placentas in response to mtDNA treatment. To assess whether this inflammatory response was tissue-specific, we evaluated mRNA expression of inflammatory genes in maternal kidneys. Treatment with mtDNA increased the levels of IL-1β (2−ΔCT, median (IQR); saline: 1.05 (1.1) vs. mtDNA: 10.17 (8.0), p=0.008) and IL-6 (saline: 0.98 (1.76) vs. mtDNA: 6.8 (3.5), p=0.002). mtDNA treatment did not affect kidney TNF-α and IL-10 expression (p>0.05). In contrast, expression of F4/80 (saline: 0.87 (2.2) vs. mtDNA: 12.5 (12.4), p=0.003) and MCP-1 (saline: 0.9 (1.7) vs. mtDNA: 7.4 (8.3), p=0.011) was greater in maternal kidneys from mtDNA-treated rats vs. controls. TLR9 expression increased in placentas (saline: 1.29 (0.5) vs. mtDNA: 4.0 (7.8), p<0.0001) and maternal kidneys (saline: 1.2 (1.8) vs. mtDNA: 4.7 (4.6), p=0.045) in response to mtDNA treatment. Conclusion: Exposure to an in vivo challenge with extracellular mtDNA during pregnancy induces a pro-inflammatory response in placentas and kidneys from pregnant rats. These responses may be mediated by TLR9 signaling activation.

NIH R01-HL0146562.

This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.